| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From Brauweg 19, Goettingen, Germany (D.P.); Department of Pediatrics and Pediatric Neurology, Georg August University Goettingen, Germany (K.R., J.G., F.H.); Department of Virology, Georg August University Goettingen, Germany (B.K.); Department of Medical Statistics, Georg August University Goettingen, Germany (E.K., E.B.); and Department of Pediatrics, University of Giessen, Germany (H-J.W.).
Address correspondence and reprint requests to Daniela Pohl, Brauweg 19, 37073 Goettingen, Germany; e-mail: dani.pohl{at}gmx.net
We studied seroprevalence and concentrations of Epstein–Barr virus (EBV) antibodies in 147 pediatric patients with multiple sclerosis (MS) and paired controls. The children with MS showed a near-complete seropositivity for EBV antibody against virus capsid antigen (98.6% vs 72.1% in controls, p = 0.001) but did not display serologic evidence for a recent EBV infection. EBV antibody concentrations of pediatric patients with MS were significantly higher vs controls.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the December 12 issue to find the title link for this article.
This work was supported by a grant of the Hertie-Stiftung (GHS 191/00).
Disclosure: The authors report no conflicts of interest.
Received May 19, 2006. Accepted in final form August 8, 2006.
This article has been cited by other articles:
|
|
 |
|
  Y. Mikaeloff, G. Caridade, S. Suissa, M. Tardieu, and on Behalf of the KIDSEP Study Group Clinically Observed Chickenpox and the Risk of Childhood-onset Multiple Sclerosis Am. J. Epidemiol., May 15, 2009; 169(10): 1260 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P Pender, P A Csurhes, A Lenarczyk, C M M Pfluger, and S R Burrows Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lindsey, L. Hatfield, M. Crawford, and S Patel Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis Multiple Sclerosis, February 1, 2009; 15(2): 153 - 158. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Jilek, M. Schluep, P. Meylan, F. Vingerhoets, L. Guignard, A. Monney, J. Kleeberg, G. Le Goff, G. Pantaleo, and R. A. Du Pasquier Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis Brain, July 1, 2008; 131(7): 1712 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Alvarez-Lafuente, M Garcia-Montojo, V De Las Heras, M. Dominguez-Mozo, M Bartolome, M. Benito-Martin, and R Arroyo Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients Multiple Sclerosis, June 1, 2008; 14(5): 595 - 601. [Abstract] [PDF]
|
|
|
|
|
|
M. Habek, V. V Brinar, and S. Hajnsek The association of multiple sclerosis and Hodgkin's disease: the role of Epstein--Barr virus infection Multiple Sclerosis, March 1, 2008; 14(2): 284 - 287. [Abstract] [PDF]
|
|
|
|
|
|
B. L. Banwell Through the eyes of a child: research insights gained through the study of childhood multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 4 - 5. [PDF]
|
|
|
|
|
|
B. Krone, D. Pohl, K. Rostasy, E. Kahler, E. Brunner, F. Oeffner, J. M. Grange, J. Gartner, and F. Hanefeld Common infectious agents in multiple sclerosis: a case control study in children Multiple Sclerosis, January 1, 2008; 14(1): 136 - 139. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds, P. Cinque, L. Andreoni, P. Trivedi, M. Salvetti, A. Faggioni, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain J. Exp. Med., November 26, 2007; 204(12): 2899 - 2912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lunemann, T. Kamradt, R. Martin, and C. Munz Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis? J. Virol., July 1, 2007; 81(13): 6777 - 6784. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Ransohoff Natalizumab for Multiple Sclerosis N. Engl. J. Med., June 21, 2007; 356(25): 2622 - 2629. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Ness, D. Chabas, A. D. Sadovnick, D. Pohl, B. Banwell, B. Weinstock-Guttman, and for the International Pediatric MS Study Group Clinical features of children and adolescents with multiple sclerosis Neurology, April 17, 2007; 68(16_suppl_2): S37 - S45. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
